Cargando…
Treatment of Rapid Progression of Myopia: Case Series and Literature Review
This retrospective case series demonstrates the combination of 0.05% atropine with MiSight<sup>®</sup> 1 day (Cooper vision, Sar Ramon, CA, USA) in rapid progression of myopia of 4 children. MiSight<sup>®</sup> 1 day is a peripheral defocus, center-distance soft contact lens...
Autores principales: | Erdinest, Nir, London, Naomi, Levinger, Nadav, Lavy, Itay, Pras, Eran, Morad, Yair |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647107/ https://www.ncbi.nlm.nih.gov/pubmed/34950014 http://dx.doi.org/10.1159/000519629 |
Ejemplares similares
-
Decreased effectiveness of 0.01% atropine treatment for myopia control during prolonged COVID-19 lockdowns
por: Erdinest, Nir, et al.
Publicado: (2022) -
Myopia control utilizing low-dose atropine as an isolated therapy or in combination with other optical measures: A retrospective cohort study
por: Erdinest, Nir, et al.
Publicado: (2022) -
Peripheral Defocus and Myopia Management: A Mini-Review
por: Erdinest, Nir, et al.
Publicado: (2023) -
Myopia Control with Combination Low-Dose Atropine and Peripheral Defocus Soft Contact Lenses: A Case Series
por: Erdinest, Nir, et al.
Publicado: (2021) -
Vision through Healthy Aging Eyes
por: Erdinest, Nir, et al.
Publicado: (2021)